Status:
UNKNOWN
Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex)
Lead Sponsor:
Epax Norway AS
Collaborating Sponsors:
Møreforsking AS
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study determines the EPA DHA uptake from different omega-3 supplements against a control.
Detailed Description
The chronic uptake of omega-3 fatty acids EPA and DHA are commonly determined by measurement of EPA and DHA in red bloods cells and presented as a % of total fatty acids, the so-called Omega-3 Index. ...
Eligibility Criteria
Inclusion
- Men or women, ≥18 -65 years of age.
- Willing to refrain from taking omega-3 supplements for 1 month prior to study start
- Willing to take study supplement for 2 months
Exclusion
- Subjects with known allergy to fish products
- Subjects known to be pregnant or breast feeding
Key Trial Info
Start Date :
March 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04768595
Start Date
March 3 2021
End Date
August 1 2021
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Møreforsking AS
Ålesund, Norway, 6006